UNITED THERAPEUTICS (NASDAQ:UTHR)
44.91
+0.10 (0.22%)
| UNITED THERAPEUTICS (NASDAQ:UTHR) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $44.81 | 52 Week High | $100.96 | ||
| Open | $44.50 | 52 Week Low | $40.33 | ||
| Day High | $45.08 | P/E | N/A | ||
| Day Low | $44.25 | EPS | $-1.34 | ||
| Volume | 627,074 | ||||
| More UTHR Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| GENZ | 2 | AMGN | 2 |
| BCS | 1 | GENZ | 1 |
| ACU | 1 | ANDS | 1 |
| BBW | 1 | BVN | 1 |
| CME | 1 | DCOM | 1 |
| EPIC | 1 | FOLD | 1 |
Entities who have mentioned UTHR
- Deutsche Bank | View Related Stories »
- UBS | View Related Stories »
- Citi | View Related Stories »
- Barclays | View Related Stories »
- 13G | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Collins Stewart | View Related Stories »
- Jefferies & Co | View Related Stories »
- SAC Capital | View Related Stories »
- Steven A. Cohen | View Related Stories »
- Standard & Poor's | View Related Stories »
- JPMorgan | View Related Stories »
- Daniel Loeb | View Related Stories »
- Scopia Capital | View Related Stories »
- Piper Jaffray | View Related Stories »
- Brean Murray Carret & Co. | View Related Stories »
- Morningstar, Inc. | View Related Stories »
- Trading Radar | View Related Stories »
- Carl Icahn | View Related Stories »
- Third Point LLC | View Related Stories »
- Banc of America | View Related Stories »
- Soleil Securities | View Related Stories »
- Hedge Funds | View Related Stories »
- Wedbush Morgan | View Related Stories »
- Dividend | View Related Stories »
View All Major News StreetInsider.com Major News for UTHR
- United Therapeutics (UTHR) Tops Estimates, Posts Q3 $0.66
- United Therapeutics (UTHR) Reports Q2 Loss of $0.09
- United Therapeutics (UTHR) Announces FDA Approval For Pulmonary Arterial Hypertension Treatment TYVASO
View All ReportsStreetInsider.com Reports on UTHR
- United Therapeutics (UTHR) Tops Estimates, Posts Q3 $0.66
- Trading Radar for 10/29: Exxon (XOM), Motorola (MOT), Waste Management (WM) Report
- United Therapeutics (UTHR) November volatility at 56, January at 43 into EPS
- United Therapeutics (UTHR) Sees Upside On Takeover Talk
- Stocks That Could Rise As Cases Of The Swine Flu Increase (RAD, GENZ, GILD, UTHR, XRAY)
View All Press ReleasesCompany Press Releases on UTHR
- United Therapeutics Corporation Reports Third Quarter 2009 Financial Results
- United Therapeutics Corporation to Announce Third Quarter 2009 Financial Results Before Market Open on Thursday, October 29, 2009
StreetInsider Reports on UTHR by Category
View All BlogsBlogs on UTHR
- Determining Potential in Health Care Stocks
- Biotech: Q3 Market Update
- Best Performing Mid and Small Cap Stocks Since 10/9/07 Peak
- Tuesday Options Recap
- Analyst upgrades, downgrades and initiations: BKC, GPS, JCP, MMM, RF, UBS ...
View All FilingsSEC Filings on UTHR
- Form 4 UNITED THERAPEUTICS CORP For: Nov 20 Filed by: MAHON PAUL A
- Form SC 13G UNITED THERAPEUTICS CORP Filed by: PICTET & CIE EUROPE SA
- Form SC 13G UNITED THERAPEUTICS CORP Filed by: PICTET & CIE EUROPE SA
- Form 10-Q UNITED THERAPEUTICS CORP For: Sep 30
- Form 8-K UNITED THERAPEUTICS CORP For: Oct 29
Comments on recent UTHR articles
Comments on UTHR
No comments are currently available.
on Oct 29, 2008
at 12:11 PM upgrade did you short the stock
Article: Brean Murray Upgrades United Therapeutics (UTHR) to Buy
on Feb 20, 2008
at 03:42 PM INSM A $3.00 dollar stock trading below a $1.00.
Article: Analyst Call of the Year: Collins Stewart on Encysive (ENCY)